ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,099, issued on March 17, was assigned to Beijing Youcare Kechuang Pharmaceutical Technology Co. Ltd. (Beijing).

"Ribose-modified cap analog and use thereof" was invented by Honglei Zhang (Beijing), Gengshen Song (Beijing), Yangjian Liu (Beijing), Kai Dong (Beijing), Yuqing Ma (Beijing), Chao Zhang (Beijing), Yanfeng Wang (Beijing), Guoliang Zhang (Beijing), Lili Jiang (Beijing) and Jinyu Zhang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a ribose-modified cap analog and a use thereof, and belongs to the technical field of chemical and biological engineering. The ribose-modified cap analog has a structure o...